May 31, 2024 10:23AM
Oct 11, 2021 12:31PM
Oct 11, 2021 12:30PM
Sep 28, 2021 08:00AM
Sep 22, 2021 08:00AM
Sep 13, 2021 06:47AM
Sep 13, 2021 06:45AM Ocular Therapeutix™ Updates Monthly In-Market Unit Sales of DEXTENZA® Billable Inserts
Sep 7, 2021 08:00AM
Aug 10, 2021 08:00AM
Aug 9, 2021 04:01PM
Aug 5, 2021 06:05PM
Aug 5, 2021 04:01PM
Jul 29, 2021 08:00AM
Jul 28, 2021 08:00AM Ocular Therapeutix™ To Report Second Quarter 2021 Financial Results
Jul 23, 2021 08:00AM
Jul 23, 2021 08:00AM
Jul 22, 2021 04:08PM
Jul 22, 2021 04:01PM
Jun 29, 2021 08:02AM
Jun 29, 2021 08:00AM
May 26, 2021 08:00AM Ocular Therapeutix™ to Participate at Three Upcoming Investor Conferences
May 5, 2021 04:01PM
May 3, 2021 06:16PM
May 3, 2021 08:00AM
Apr 29, 2021 08:00AM
Apr 28, 2021 08:00AM
Mar 11, 2021 04:01PM
Mar 4, 2021 04:02PM Ocular Therapeutix (OCUL) Announces FDA Acceptance of sNDA for DEXTENZA for Treatment of Ocular Itching Associated with Allergic Conjunctivitis
Mar 4, 2021 04:01PM
Mar 1, 2021 07:16AM
Mar 1, 2021 07:00AM
Feb 12, 2021 08:00AM
Feb 4, 2021 04:01PM
Jan 20, 2021 08:01AM
Jan 20, 2021 08:00AM Ocular Therapeutix™ Presents Interim Topline Data from the Phase 1 Clinical Trial of OTX-TIC in Patients with Primary Open Angle Glaucoma or Ocular Hypertension at the 10th Annual Glaucoma 360 New H
Jan 7, 2021 08:00AM
Dec 22, 2020 08:46AM
Dec 22, 2020 08:45AM
May 10, 2019 07:30AM
Apr 2, 2019 08:16AM
Apr 2, 2019 08:15AM
Dec 3, 2018 09:42AM Ocular Therapeutix (OCUL) PT Raised to $24 at Cantor Fitzgerald on DEXTENZA Approval
Dec 3, 2018 07:01AM
Dec 3, 2018 07:00AM
Nov 7, 2018 04:01PM
Oct 31, 2018 08:00AM
Oct 19, 2018 07:50AM
Oct 19, 2018 07:50AM
Oct 15, 2018 09:11AM Top 6 Healthcare Names To Buy On Weakness - Piper Jaffray
Sep 26, 2018 08:00AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All